Site Meter
Home » Archives » Moderna Therapeutics Expands In New HQ And Lab In Cambridge, MA

Moderna Therapeutics Expands In New HQ And Lab In Cambridge, MA

From Left to Right: Tim Toomey, Massachusetts State Representative, Cambridge; Noubar Afeyan, Co-founder and Chairman, Moderna; Managing Partner & CEO, Flagship Ventures; Stephane Bancel, President and Founding CEO, Moderna; Angus McQuilken, Vice President for Communications & Marketing, Massachusetts Life Sciences Center. (PRNewsFoto/Moderna Therapeutics)

Posted by Heidi Schwartz

Moderna Therapeutics has announced the expansion of its headquarters to Technology Square in Cambridge, MA. With the addition of the new space, Moderna will have up to 100 full-time employees at two locations by the end of 2013.

“We are thrilled to expand our presence in Massachusetts, the country’s most important hub of biotech innovation, which has been a great source of talent and ideas to Moderna from its earliest days,” said Stephane Bancel, president and founding CEO of Moderna.

The new site will be the center of Moderna’s R&D and provide a significant increase in laboratory space for formulation, screening, and both in-vivo and in-vitro studies. The facility houses administrative and corporate needs as well as IT specialists and is equipped with state of the art technology to enable virtual collaboration and cloud-based computing. Moderna’s previous Cambridge headquarters will continue to serve as an additional site for manufacturing and quality.

“In Massachusetts, we invest in the life sciences because we are choosing to shape our own future,” said Gov. Deval Patrick. “I congratulate Moderna on their new facility and look forward to the jobs and economic opportunities they will bring.”

“On behalf of the team at the Massachusetts Life Sciences Center, congratulations to Moderna on its expansion here in the Commonwealth,” said MLSC President & CEO Dr. Susan Windham-Bannister. “We are pleased to have awarded Moderna 2011 and 2012 Tax Incentives tied to their new job creation in Massachusetts and look forward to the great R&D efforts in ‘messenger RNA Therapeutics’ that will be taking place in this new space.”

email

About The Author

Schwartz joined Group C Media in April 1989 as managing editor of Today's Facility Manager. In September 2012, she transitioned to a new role dedicated to developing online content for Business Facilities and Today's Facility Manager. Schwartz can be reached at [email protected]

Number of Entries : 658

Leave a Comment

© 2014 Business Facilities Magazine | Group C Media | Privacy Policy | Terms Of Use